{"result": "(\"entity\"<|>CLIN NUTR<|>ORGANIZATION<|>Clin Nutr is a journal that publishes research and guidelines related to clinical nutrition, including studies on chronic intestinal failure.)\n##\n(\"entity\"<|>NUTRICIÓN<|>EVENT<|>Nutritional therapy and dietary management for patients, particularly those requiring specialized feeding methods.)\n##\n(\"entity\"<|>ILEOSTOMÍA<|>EVENT<|>A surgical procedure that creates an opening in the abdominal wall for waste elimination, which can affect nutritional absorption.)\n##\n(\"entity\"<|>PROTEÍNAS<|>EVENT<|>Essential nutrients that are part of the dietary regimen for patients receiving parenteral nutrition.)\n##\n(\"entity\"<|>AGENTES NUTRICIONALES<|>EVENT<|>Nutritional agents used in parenteral nutrition to provide essential calories and nutrients to patients.)\n##\n(\"entity\"<|>DIETA SIN RESIDUOS<|>EVENT<|>A dietary regimen that minimizes waste and is easy to digest, often recommended for patients with specific medical conditions.)\n##\n(\"entity\"<|>EQUIPO MULTIDISCIPLINARIO<|>ORGANIZATION<|>A multidisciplinary team that provides nutritional support and management for patients requiring home parenteral nutrition.)\n##\n(\"relationship\"<|>PACIENTE<|>ILEOSTOMÍA<|>The patient has undergone an ileostomy, which impacts their nutritional management<|>5)\n##\n(\"relationship\"<|>PACIENTE<|>DIETA SIN RESIDUOS<|>The patient follows a diet without residues to aid in their nutritional recovery<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>PROTEÍNAS<|>The patient receives a specific amount of proteins as part of their parenteral nutrition regimen<|>7)\n##\n(\"relationship\"<|>ESPEN<|>EQUIPO MULTIDISCIPLINARIO<|>ESPEN guidelines are utilized by the multidisciplinary team to manage home parenteral nutrition<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN<|>NUTRICIÓN PARENTERAL<|>Nutritional therapy is a broader category that includes home parenteral nutrition as a specific method<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN<|>AGENTES NUTRICIONALES<|>Nutritional therapy involves the use of various nutritional agents to meet dietary needs<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: • Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, et al; Home Artificial Nutrition & Chronic Intestinal Failure Special\n                                                                                                                                                                Interest Group of ESPEN. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247-307.\n\n\n\n242                                                                                                                                                                                                                                                                                           243\n---\n                                                                                                                                                                                                                                              NUTRICIÓN                           4\n\n\n\n     51  La paciente ha continuado recibiendo nutrición parenteral domiciliaria de forma                                                               52  Respecto a la prescripción de una nutrición parenteral domiciliaria, ¿cuál de las\n         prolongada. Las pérdidas por la ileostomía se han estabilizado en unos 1.300 ml diarios                                                           siguientes condiciones no es correcta?\n         conservando diuresis de 1.100-1.200 ml. Ha vuelto a su peso habitual de                                                                           A. Debe tener una duración prevista de al menos 2 semanas.\n         50 kg (IMC 23) y ha recuperado una vida activa reincorporándose incluso a su actividad\n         laboral. Se ha ido disminuyendo el aporte parenteral progresivamente, pero se                                                                     B. La expectativa de vida suficiente debe ser igual o superior a 3 meses.\n         considera que no es factible reducir más el aporte en los últimos meses. Recibe                                                                   C. Debe manejarse por un equipo multidisciplinario de soporte nutricional con experiencia\n         una nutrición parenteral con un aporte diario de 1.400 kcal, 40 g de proteínas y                                                                      y capacidad de prescripción, seguimiento y asistencia en nutrición parenteral domiciliaria.\n         1.200 ml de volumen 6 días a la semana y realiza una dieta sin residuos de fácil                                                                  D.  El entorno familiar debe tener capacidad y motivación para asumir el tratamiento.\n         digestión fraccionada en 6 tomas. La función renal y hepática es normal y\n         mantiene un buen estado de hidratación.                                                                                                           COMENTARIO\n         Una de las posibles complicaciones que puede presentar es la aparición de hepatopatía\n         asociada a la nutrición parenteral domiciliaria (NPD). ¿Cuál de las siguientes medidas                                                            Las guías del Sistema Nacional de Salud recomiendan valorar una serie de factores ante la\n         no es útil para prevenir la aparición del daño hepático asociado a NP?                                                                            prescripción de una nutrición parenteral domiciliaria (NPD):\n         A. Reducir el aporte de aminoácidos ramificados en la bolsa de NP.                                                                                •  Factores relacionados con el enfermo:\n         B. Potenciar la ingesta oral/enteral ajustando el aporte calórico en NP a la baja.                                                                   ―   Imposibilidad de nutrición adecuada y suficiente por vía oral-enteral.\n                                                                                                                                                              ―   Duración prevista del tratamiento de, al menos, 4-5 semanas.\n         C. Cuando existe enfermedad hepática asociada al fallo intestinal conviene revisar el aporte                                                         ―   Situación clínica y emocional que permita su tratamiento a domicilio.\n             lipídico disminuyendo el cociente de ácidos grasos insaturados ω-6/ω-3.                                                                          ―   En el caso de enfermos autónomos, capacidad de adquirir los conocimientos.\n         D.  Extremar los cuidados del catéter usando los protocolos establecidos para prevenir                                                            •  Expectativa de vida suficiente (igual o superior a 3 meses).\n             episodios de sepsis.                                                                                                                             ―   Aceptación del tratamiento por el enfermo, que se reflejará mediante la firma del con-\n                                                                                                                                                                  sentimiento informado.\n         COMENTARIO                                                                                                                                           ―   En los casos de inicio hospitalario, tolerancia demostrada a la NP.\n         La enfermedad         hepática asociada al         fallo intestinal se     define   como el daño que sufre el                                     •  Factores relacionados con el sistema sanitario:\n         hígado como consecuencia de diversos factores ligados al fallo intestinal, más allá de la                                                            ―   Disponibilidad de un equipo multidisciplinario de soporte nutricional con experiencia\n         administración de nutrición parenteral. Para su prevención es recomendable:                                                                              y capacidad de prescripción, seguimiento y asistencia en NPD.\n         •  Prevenir la sepsis, o controlarla si está presente.                                                                                               ―   Disponibilidad de una red eficaz de suministro de la fórmula, material y equipamiento.\n         •  Intentar preservar la máxima longitud de intestino delgado y mantener el colon en conti-                                                          ―   Colaboración del equipo de apoyo en el domicilio (enfermero-médico).\n            nuidad con el intestino delgado.                                                                                                                  ―   Protocolización de todo el proceso.\n         •  Mantener la ingesta oral o enteral.                                                                                                            •  Factores relacionados con el entorno sociofamiliar:\n         •  Administrar la nutrición parenteral de forma cíclica.                                                                                             ―   Capacidad y motivación del entorno familiar para asumir el tratamiento.\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ESPEN<|>ORGANIZATION<|>ESPEN is the European Society for Clinical Nutrition and Metabolism, which provides guidelines on nutrition and chronic intestinal failure.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutritional therapy administered intravenously to patients who cannot obtain nutrition through the digestive tract.)\n##\n(\"entity\"<|>HEPATOPATÍA<|>EVENT<|>Liver disease associated with home parenteral nutrition, which can occur due to various factors related to intestinal failure.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>A patient receiving home parenteral nutrition and has stabilized losses due to ileostomy while maintaining a normal renal and hepatic function.)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN PARENTERAL<|>The patient is receiving home parenteral nutrition as part of their treatment plan<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>HEPATOPATÍA<|>The patient is at risk of developing hepatopathy associated with home parenteral nutrition<|>6)\n##\n(\"relationship\"<|>ESPEN<|>NUTRICIÓN PARENTERAL<|>ESPEN provides guidelines for the administration and management of home parenteral nutrition<|>7)\n<|COMPLETE|>"}]}